5-Azacytidine suppresses the proliferation of pancreatic cancer cells by inhibiting the Wnt/β-catenin signaling pathway

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 5064-5072

  Zhang, H ^a   Zhou, W C ^a   Li, X ^a   Meng, W B ^a   Zhang, L ^a   Zhu, X L ^a   Zhu, K X ^a   Bai, Z T ^a   Yan, J ^a   Liu, T ^a   Xu, X C ^a   Li, Y M ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

5 Azacytidine; c Myc; CyclinD1; Pancreatic cancer; Wnt catenin

Indexed keywords

AZACITIDINE; BETA CATENIN; CYCLIN D1; MESSENGER RNA; MYC PROTEIN; WNT PROTEIN; ANTINEOPLASTIC ANTIMETABOLITE; CCND1 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; MYC PROTEIN, HUMAN;

ANALYTIC METHOD; APOPTOSIS; ARTICLE; BETA CATENIN GENE; CANCER INHIBITION; CCK8 METHOD; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PANCREATIC CANCER CELL LINE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; METABOLISM; PANCREAS; PATHOLOGY; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; GENE EXPRESSION REGULATION; HUMANS; PANCREAS; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION;

EID: 84903941171     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.July.4.22     Document Type: Article

References (21)

1. Abba MC, Laguens RM, Dulout FN and Golijow CD (2004). The c-myc activation in cervical carcinomas and HPV 16 infections. Mutat. Res. 557: 151-158.
2. Cai HH, Sun YM, Miao Y, Gao WT, et al. (2011). Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines. Hepatobiliary Pancreat. Dis. Int. 10: 95-100.
3. Clevers H (2006). Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
4. Da Forno PD, Pringle JH, Hutchinson P, Osborn J, et al. (2008). WNT5A expression increases during melanoma progression and correlates with outcome. Clin. Cancer Res. 14: 5825-5832.
5. Dessimoz J, Bonnard C, Huelsken J and Grapin-Botton A (2005). Pancreas-specific deletion of beta-catenin reveals Wnt-dependent and Wnt-independent functions during development. Curr. Biol. 15: 1677-1683.
6. Garcea G, Dennison AR, Pattenden CJ, Neal CP, et al. (2008). Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP 9: 99-132.
7. Griesmann H, Ripka S, Pralle M, Ellenrieder V, et al. (2013). WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer. Neoplasia 15: 11-22.
8. Gunda V, Cogdill AP, Bernasconi MJ, Wargo JA, et al. (2013). Potential role of 5-aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer. Surgery 154: 1456-1462.
9. Hackert T and Buchler MW (2013). Pancreatic cancer: advances in treatment, results and limitations. Dig. Dis. 31: 51-56.
10. Han X, Tan ZJ, Guo RD, Li ZJ, et al. (2013). Effect of 5-aza-2'-deoxycytidine on growth and methylation of RUNX3 gene in human pancreatic cancer cell line MiaPaca2. Zhonghua Zhong. Liu Za Zhi. 35: 17-21.
11. Iwaya K, Ogawa H, Kuroda M, Izumi M, et al. (2003). Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis. Clin. Exp. Metastasis 20: 525-529.
12. Jagou-Yuschak AF, Badra R, Ballario F, Montyn G, et al. (2013). Solid pseudopapillary tumor of the pancreas: a case report and a review of the literature. Acta Gastroenterol. Latinoam. 43: 139-142.
13. Jones S, Zhang X, Parsons DW, Lin JC, et al. (2008). Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
14. Mikysková R, Indrová M, Vlková V, Bieblová J, et al. (2014). DNA demethylating agent 5-azacytidine inhibits myeloid-derived suppressor cells induced by tumor growth and cyclophosphamide treatment. J. Leukoc. Biol. [Epub ahead of print].
15. Morris JP, Wang SC and Hebrok M (2010). KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat. Rev. Cancer 10: 683-695.
16. Murtaugh LC, Law AC, Dor Y and Melton DA (2005). Beta-catenin is essential for pancreatic acinar but not islet development. Development 132: 4663-4674.
17. Nalls D, Tang SN, Rodova M, Srivastava RK, et al. (2011). Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One 6: e24099.
18. Vincent A, Omura N, Hong SM, Jaffe A, et al. (2011). Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma. Clin. Cancer Res. 17: 4341-4354.
19. Wang L, Heidt DG, Lee CJ, Yang H, et al. (2009). Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell 15: 207-219.
20. Wang Q, Cai J, Cai XH and Chen L (2013). miR-346 regulates osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting the Wnt/beta-catenin pathway. PLoS One 8: e72266.
21. Wang S, Liu H, Akhtar J, Chen HX, et al. (2013). Alteration of runt-related transcription factor 3 gene expression and biologic behavior of esophageal carcinoma TE-1 cells after 5-azacytidine intervention. Asian Pac. J. Cancer Prev. 14: 5427-5433.